Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,378,883 papers from all fields of science
Search
Sign In
Create Free Account
TGN-1412 monoclonal antibody
Known as:
TGN 1412
, monoclonal antibody TGN1412
, TAB08
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Antibodies, Monoclonal, Humanized
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Author response for "Human Fcγ receptors compete for TGN1412 binding which determines the antibody's effector function"
Simone Dudek
,
Sabrina Weissmüller
,
+5 authors
Z. Waibler
2019
Corpus ID: 155502115
2018
2018
Katastrofa u ispitivanju I. faze sa "superagonistom" TGN1412
Suzana Mimica Matanović
2018
Corpus ID: 165190342
2018
2018
Faculty Opinions recommendation of The rise and fall of the CD28 superagonist TGN1412 and its return as TAB08: a personal account.
L. Tuosto
2018
Corpus ID: 158614938
2013
2013
This information is current as PreClinical Testing of Immunotherapeutics Understanding the Causes to Improve Monoclonal Antibody TGN1412: Better ''Cytokine Storm'' in the Phase I Trial of
S. Poole
,
J. Thorpe
,
+10 authors
Cherry Edwards
2013
Corpus ID: 251930507
and Stephen PooleJ. Thorpe, Adrian Bristow, Meenu Wadhwa, Robin ThorpeTarrant, Jane Robinson, Tony Meager, Carl Dolman, Susan…
Expand
Review
2007
Review
2007
Review of New Challenges for the Development of Early Phase Biologic Compounds in the Wake of the TGN1412 Clinical Trial
A. J. Mackey
,
C. Wadsworth
2007
Corpus ID: 71874818
2006
2006
Will volunteers still want to take part in research after the TGN1412 trial
Tom Moberly
2006
Corpus ID: 59310160
2006
2006
[New catastrophe in pharmacological treatment--the crisis of clinical studies? Acute organ failure after administration of TGN1412].
P. Jerie
Casopis lekaru ceskych
2006
Corpus ID: 12578999
2006
2006
Drug giants hamstrung by timid middle management
R. Firestone
Nature
2006
Corpus ID: 4372760
SIR — Your News story about the recent clinical-trial disaster, “Can super-antibody drugs be tamed?” (Nature 440, 855–856; 2006…
Expand
2006
2006
Disaster in phase I clinical trial with TGN1412 superagonist
S. Matanović
2006
Corpus ID: 80231653
This paper describes phase I clinical trial, which ended with cytokine storm and life-threatening adverse events in 6…
Expand
2006
2006
TGN1412: Superagonist Dr. Jekyll and Superantigen Mr. Hyde
G. Criado
2006
Corpus ID: 36032949
Los anticuerpos anti-CD28 superagonistas inducen activación de los linfocitos T en ausencia de estimulación del TCR. Los ensayos…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required